Results for tag: "Mitochondrial Electron Transport Inhibitor"

Mitochondrial electron transport inhibitors are a class of drugs used to treat diseases of the central nervous system (CNS). These drugs act by blocking the electron transport chain in the mitochondria, which is responsible for producing energy in the form of ATP. This inhibition leads to a decrease in the production of reactive oxygen species, which can cause oxidative damage to cells. This can help to reduce inflammation and improve neurological function. Mitochondrial electron transport inhibitors are used to treat a variety of CNS disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and Huntington's disease. Some companies in the mitochondrial electron transport inhibitor market include AbbVie, AstraZeneca, Biogen, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more